Aciphex and Ursodiol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Aciphex (rabeprazole sodium) and Ursodiol (ursodiol). Common drug interactions include renal haemorrhage among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Aciphex and Ursodiol. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.
What is Aciphex?
Aciphex has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 25,301 Aciphex users. Check the latest studies of Aciphex.
What is Ursodiol?
Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 19,061 Ursodiol users. Check the latest studies of Ursodiol.
53 people who take Aciphex and Ursodiol together, and have interactions are studied.

What are the common drug interactions of Aciphex and Ursodiol, by gender? *:
female:
- Renal haemorrhage (bleeding from kidney)
- Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Scar
- Scleroderma (hard skin)
- Skin lesion
- Visual acuity reduced (reduced clearness of vision)
- Vitamin d deficiency
- Vomiting
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
male:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Clostridial infection (infectious conditions by clostridium bacteria)
- Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
- Hyperkalaemia (damage to or disease of the kidney)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Diarrhoea
- Vomiting
- Cheilitis (infection of lips)
- Gout (uric acid crystals building up in the body)
What are the common drug interactions of Aciphex and Ursodiol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Vomiting
10-19:
n/a
20-29:
- Infection
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Nephrolithiasis (calculi in the kidneys)
- Abdominal pain upper
- Cystic fibrosis (disease of the secretary glands)
- Pulmonary thrombosis (scarring in the lungs)
30-39:
- Hepatic infection
- Liver transplant rejection (failure of liver transplant)
- Neutropenia (an abnormally low number of neutrophils)
40-49:
- Diarrhoea
- Drug ineffective
50-59:
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Decreased appetite
- Disturbance in attention
- Dysgeusia (disorder of the sense of taste)
- Dysuria (painful or difficult urination)
- Hair disorder
- Hypoaesthesia (reduced sense of touch or sensation)
- Irritability
- Lethargy (tiredness)
- Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
60+:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Hyperkalaemia (damage to or disease of the kidney)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Clostridial infection (infectious conditions by clostridium bacteria)
- Diarrhoea
- Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
- Vomiting
- Cheilitis (infection of lips)
- Gout (uric acid crystals building up in the body)
What are the existing conditions these people have? *
- Pain: 13 people, 24.53%
- High Blood Cholesterol: 12 people, 22.64%
- Cystic Fibrosis (disease of the secretary glands): 10 people, 18.87%
- Gout (uric acid crystals building up in the body): 9 people, 16.98%
- Hypersensitivity: 7 people, 13.21%
- High Blood Pressure: 6 people, 11.32%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 11.32%
- Back Pain: 5 people, 9.43%
- Cardiac Disorder: 5 people, 9.43%
- Sleep Disorder: 5 people, 9.43%
* Approximation only. Some reports may have incomplete information.
Do you take Aciphex and Ursodiol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Aciphex and Ursodiol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aciphex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ursodiol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aciphex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ursodiol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on rabeprazole sodium and ursodiol (the active ingredients of Aciphex and Ursodiol, respectively), and Aciphex and Ursodiol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Valacyclovir and Vasovagal for Women aged 50-59 - 3 seconds ago
- Valacyclovir and Syncope for Women aged 50-59 - 3 seconds ago
- Valacyclovir and Passed Out for Women aged 50-59 - 4 seconds ago
- Valacyclovir and Lightheadedness - Fainting for Women aged 50-59 - 4 seconds ago
- Valacyclovir and Fainting for Women aged 50-59 - 4 seconds ago
- Drug interactions of Bactrim and Vitamin K1 - 14 seconds ago
- Drug interactions of Nifedipine and Lamivudine - 25 seconds ago
- Chronic Fatigue Syndrome in Infumorph, how severe and when it was recovered? - 36 seconds ago
- Urticaria Aggravated and Urinary Tract Infection - 37 seconds ago
- Natpara and Pain for Women aged 40-49 - 46 seconds ago